InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,035.60
(
-0.71%
)
US TECH 100
16,931.60
(
-0.75%
)
Dow Jones
37,997.38
(
-1.21%
)
Brent Oil
87.94
(
0.83%
)
Bitcoin
64,500.05
(
0.34%
)
Post# of 3167
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Hercules1

Send PM Follow Ignore
Followers 1004
Posts 43080
Boards Moderated 0
Alias Born 03/17/2014

Hercules1

Member Level

Re: None

Thursday, 10/19/2017 2:24:33 PM

Thursday, October 19, 2017 2:24:33 PM

Post# of 3167
huge buying opportunity on this minor dip:



October 19, 2017
4:51 pm ET
*Imprimis CEO Mark Baum Tells Benzinga Co. Will Not Compound A Copy Of Restais As It Is Illegal, Will Use Patent-Pending Topical Cyclosporine Formulation To Compound Drug To The Individual Patient's Need From A Physician's Prescription
Benzinga
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
InvestorsHub NewsWire

FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM

Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM

North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM

Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM

Start posting your company's news
Only $200 per official company press release!